✨ Medicine Distribution Consents
11 JUNE NEW ZEALAND GAZETTE 1755
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Lamivudine 150 mg | Tablet, film coated | Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom | 3TC |
| Lamivudine 10 mg/mL | Solution, oral | Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom | 3TC |
| Aspirin 25 mg, dipyridamole 200 mg | Capsule, modified release | Boehringer Ingelheim Pharma KG., Biberach an der Riss, Germany and Boehringer Ingelheim Pharma KG., Ingelheim am Rhein, Germany | Asasantin Retard |
| Clotrimazole 1%, 2% | Cream, vaginal | Taro Pharmaceuticals Inc., Bramelea, Ontario, Canada | Clotrimaderm |
| Clotrimazole 1% | Cream, topical | Taro Pharmaceuticals Inc., Bramelea, Ontario, Canada | Clotrimazole |
| Felodipine 5 mg, metoprolol succinate 47.5 mg equivalent to 50 mg metoprolol tartrate; felodipine 10 mg, metoprolol succinate 95 mg equivalent to 100 mg metoprolol tartrate | Tablets, modified release | Astra Pharmaceutical Production AB., Södertälje, Sweden | Logimax |
| Fluvoxamine maleate 50 mg, 100 mg | Tablets, film coated | Solvay Duphar BV., Olst, The Netherlands | Luvox |
| Vinorelbine tartrate 13.85 mg/mL equivalent to 10 mg/mL vinorelbine | Injection, solution | Aquitaine Pharm International, Pierre Fabre Medicament Subsidiary, Idron, France | Navelbine |
| Grepafloxacin hydrochloride sesquihydrate 236.4 mg equivalent to 200 mg grepafloxacin | Tablet, film coated | Otsuka Pharmaceutical Co Limited, Tokushima-shi, Tokushima, Japan | Raxar |
| Grepafloxacin hydrochloride sesquihydrate 472.8 mg, 709.2 mg equivalent to 400 mg, 600 mg grepafloxacin | Tablets, film coated | Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom | Raxar |
| Salbutamol sulphate 60 µg/dose equivalent to 50 µg/dose salbutamol | Inhalation powder | Astra Pharmaceutical Production AB., Södertälje, Sweden | Salbutamol Turbuhaler |
| Topiramate 25 mg, 50 mg, 100 mg, 200 mg, 300 mg | Tablet, film coated | Janssen-Cilag Farmaceutica LDA., Queluz de Baixo, Queluz, Portugal | Topamax |
| Daclizumab 5mg/mL | Infusion, concentrate | Hoffmann-La Roche Inc., Nutley, New Jersey, United States of America | Zenapax |
| Zolmitriptan 2.5 mg, 5 mg | Tablets, film coated | IPR Pharmaceuticals Inc., Carolina, San Juan, Puerto Rico | Zomig |
Dated this 5th day of June 1998.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
g04012
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Sulphamethoxazole 40 mg/mL, trimethoprim 8 mg/mL | Suspension, oral | Novex Pharma Inc., Richmond Hill, Ontario, Canada | Apo-Sulfatrim |
| Ciprofloxacin hydrochloride 0.35% equivalent to 0.3% ciprofloxacin | Drops, eye, solution | S A Alcon Couvreur NV., Puurs, Belgium | Ciloxan |
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1998, No 79
NZLII —
NZ Gazette 1998, No 79
✨ LLM interpretation of page content
🏥 Consent to the Distribution of a New Medicine
🏥 Health & Social Welfare5 June 1998
Medicines, Distribution, Consent, New Medicine, Schedule
- G. R. BOYD, Chief Advisor, Regulation and Safety
🏥 Consent to the Distribution of Changed Medicines
🏥 Health & Social WelfareMedicines, Distribution, Consent, Changed Medicine, Schedule